The emerging promise of personalized medicine has been widely touted. The potential for more tailored and targeted therapies is great, but the development of a profitable business focused on targeted therapies and companion diagnostics presents scientific challenges. Additional challenges include protecting the firm's intellectual property and satisfying FDA regulators. This session will address the business, scientific, and legal challenges for the commercialization of personalized medicine.

• Increase understanding of the manner in which pharmacogenetic and pharmacogenomic scientific advances have created business opportunities for personalized medicine
• Identify the legal challenges — including intellectual property and FDA regulatory challenges — that face industry seeking to exploit business opportunities for personalized medicine
• Discuss practical considerations in overcoming the legal challenges presented by personalized medicine